{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:14:33Z","timestamp":1792102473792,"version":"4.4.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,4,27]],"date-time":"2013-04-27T00:00:00Z","timestamp":1367020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00737-013-0346-y","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T17:11:05Z","timestamp":1367341865000},"page":"279-291","source":"Crossref","is-referenced-by-count":160,"title":["ISPMD consensus on the management of premenstrual disorders"],"prefix":"10.1007","volume":"16","author":[{"name":"Consensus Group of the International Society for Premenstrual Disorders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Nevatte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Michael Shaughn","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbjorn","family":"B\u00e4ckstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Dennerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Endicott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Neill","family":"Epperson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen W.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uriel","family":"Halbreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Panay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Pearlstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rubinow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Studd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Sundstr\u00f6m-Poromaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Yonkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,27]]},"reference":[{"key":"346_CR1","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. 4th ed, text revision. Washington: The Association"},{"key":"346_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/01674828609016741","volume":"5","author":"B Andersch","year":"1986","unstructured":"Andersch B, Wendestam C, Hahn L, Ohman R (1986) Premenstrual complaints. Prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gynaecol 5:39\u201349","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"346_CR3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.psyneuen.2009.02.003","volume":"34","author":"L Andr\u00e9en","year":"2009","unstructured":"Andr\u00e9en L, Nyberg S, Turkmen S, van Wingen G, Fern\u00e1ndez G, B\u00e4ckstr\u00f6m T (2009) Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 34:1121\u201332","journal-title":"Psychoneuroendocrinology"},{"key":"346_CR4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1600-0447.2001.00412.x","volume":"104","author":"J Angst","year":"2001","unstructured":"Angst J, Sellaro R, Merikangas KR, Endicott J (2001) The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand 104:110\u201316","journal-title":"Acta Psychiatr Scand"},{"key":"346_CR5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1471-0528.1981.tb01028.x","volume":"88","author":"T B\u00e4ckstr\u00f6m","year":"1981","unstructured":"B\u00e4ckstr\u00f6m T, Boyl H, Baird DT (1981) Persistence of symptoms of premenstrual tension in hysterectomized women. Br J Obstet Gynaec 88:530\u2013536","journal-title":"Br J Obstet Gynaec"},{"key":"346_CR6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00006842-198312000-00004","volume":"45","author":"T B\u00e4ckstr\u00f6m","year":"1983","unstructured":"B\u00e4ckstr\u00f6m T, Sanders D, Leask RM, Davidson D, Warner P, Bancroft J (1983) Mood, sexuality, hormones and the menstrual cycle. II. Hormone levels and their relationship to premenstrual syndrome. Psychosom Med 45:503\u20137","journal-title":"Psychosom Med"},{"key":"346_CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(92)90006-F","volume":"46","author":"T B\u00e4ckstr\u00f6m","year":"1992","unstructured":"B\u00e4ckstr\u00f6m T, Hansson-Malmstr\u00f6m Y, Lindhe BA, Cavalli-Bj\u00f6rkman B, Nordenstr\u00f6m S (1992) Contraception 46:253\u2013268","journal-title":"Contraception"},{"key":"346_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2011.03.061","volume":"191","author":"T B\u00e4ckstr\u00f6m","year":"2011","unstructured":"B\u00e4ckstr\u00f6m T, Haage D, L\u00f6fgren M, Johansson IM, Str\u00f6mberg J, Nyberg S, Andr\u00e9en L, Ossewaarde L, Wingen GA, Turkmen S, Bengtsson SK (2011) Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience 191:46\u201354","journal-title":"Neuroscience"},{"key":"346_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1258\/mi.2012.012016","volume":"18","author":"LJ Baker","year":"2012","unstructured":"Baker LJ, O\u2019Brien PMS (2012) Potential strategies to avoid progestogen-induced premenstrual disorders. Menopause Int 18:73\u201376","journal-title":"Menopause Int"},{"key":"346_CR10","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1210\/jc.2002-020755","volume":"88","author":"I Bj\u00f6rn","year":"2003","unstructured":"Bj\u00f6rn I, Sundstrom-Poromaa I, Bixo M, Nyberg S, Backstrom G, Backstrom T (2003) Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J Clin Endocrinol Metab 88:2026\u201330","journal-title":"J Clin Endocrinol Metab"},{"key":"346_CR11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/01.AOG.0000259920.73000.3b","volume":"109","author":"JE Borenstein","year":"2007","unstructured":"Borenstein JE, Dean BB, Yonkers KA, Endicott J (2007) Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. Obstet Gynecol 109:1068\u201375","journal-title":"Obstet Gynecol"},{"key":"346_CR12","first-page":"779","volume":"84","author":"CS Brown","year":"1994","unstructured":"Brown CS, Ling FW, Andersen RN, Farmer RG, Arheart KL (1994) Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol 84:779\u201386","journal-title":"Obstet Gynecol"},{"key":"346_CR13","volume":"2","author":"J Brown","year":"2009","unstructured":"Brown J, O\u2019Brien PMS, Marjoribanks J, Wyatt K (2009) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2, CD001396","journal-title":"Cochrane Database Syst Rev"},{"key":"346_CR14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000162296","volume":"78","author":"JW Busse","year":"2009","unstructured":"Busse JW, Montori VM, Krasnik C, Patelis-Siotis I, Guyatt GH (2009) Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials. Psychother Psychosom 78:6\u201315","journal-title":"Psychother Psychosom"},{"key":"346_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0002-9378(90)90831-Q","volume":"162","author":"RF Casper","year":"1990","unstructured":"Casper RF, Hearn MT (1990) The effect of hysterectomy and bilateral oophorectomy on women with severe premenstrual syndrome. Am J Obstet Gynecol 162:105\u20139","journal-title":"Am J Obstet Gynecol"},{"key":"346_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9378(90)90830-Z","volume":"162","author":"P Casson","year":"1990","unstructured":"Casson P, Hahn PM, Van Vugt DA, Reid RL (1990) Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol 162:99\u2013105","journal-title":"Am J Obstet Gynecol"},{"key":"346_CR17","first-page":"1001","volume":"84","author":"AF Chan","year":"1994","unstructured":"Chan AF, Mortola JF, Wood SH, Yen SS (1994) Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Obstet Gynecol 84:1001\u20131005","journal-title":"Obstet Gynecol"},{"key":"346_CR18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-0327(01)00458-X","volume":"70","author":"LS Cohen","year":"2002","unstructured":"Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL (2002a) Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord 70:125\u201332","journal-title":"J Affect Disord"},{"key":"346_CR19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0029-7844(02)02166-X","volume":"100","author":"LS Cohen","year":"2002","unstructured":"Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S (2002b) Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol 100:435\u2013444","journal-title":"Obstet Gynecol"},{"key":"346_CR20","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/humrep\/deh354","volume":"19","author":"WH Cronje","year":"2004","unstructured":"Cronje WH, Vashisht A, Studd JW (2004) Hyseterctomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 19:2152\u20135","journal-title":"Hum Reprod"},{"key":"346_CR21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/jwh.2008.1098","volume":"18","author":"A Daley","year":"2009","unstructured":"Daley A (2009) Exercise and premenstrual symptomatology: a comprehensive review. J Women Health (Larchmt) 18:895\u20139","journal-title":"J Women Health (Larchmt)"},{"key":"346_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/0167482X.2010.538102","volume":"32","author":"G Dante","year":"2011","unstructured":"Dante G, Facchinetti F (2011) Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol 32:42\u201351","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"346_CR23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/pgmj.67.787.450","volume":"67","author":"M Deeny","year":"1991","unstructured":"Deeny M, Hawthorn R, McKay HD (1991) Low dose danazol in the treatment of the premenstrual syndrome. Postgrad Med J 67:450\u2013454","journal-title":"Postgrad Med J"},{"key":"346_CR24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1258\/mi.2010.010035","volume":"16","author":"L Dennerstein","year":"2010","unstructured":"Dennerstein L, Lehert P, Keung LS, Pal S, Choi D (2010a) Asian study of effects of premenstrual symptoms on activities of daily life. Menopause Int 16:146\u2013151","journal-title":"Menopause Int"},{"key":"346_CR25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2009.04.023","volume":"94","author":"L Dennerstein","year":"2010","unstructured":"Dennerstein L, Lehert P, B\u00e4ckstr\u00f6m TC, Heinemann K (2010b) The effect of premenstrual symptoms on activities of daily life. Fertil Steril 94:1059\u201364","journal-title":"Fertil Steril"},{"key":"346_CR26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1258\/mi.2011.011027","volume":"17","author":"L Dennerstein","year":"2011","unstructured":"Dennerstein L, Lehert P, Heinemann K (2011) Global study of women\u2019s experiences of premenstrual symptoms and their effects on daily life. Menopause Int 17:88\u201395","journal-title":"Menopause Int"},{"key":"346_CR27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archfami.8.2.122","volume":"8","author":"P Deuster","year":"1999","unstructured":"Deuster P, Adera T, South-Paul J (1999) Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med 8:122\u201328","journal-title":"Arch Fam Med"},{"key":"346_CR28","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(00)02754-9","volume":"356","author":"PW Dimmock","year":"2000","unstructured":"Dimmock PW, Wyatt KM, Jones PW, O'Brien PM (2000) Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome; a systematic review. Lancet 356:1131\u20136","journal-title":"Lancet"},{"key":"346_CR29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF03004171","volume":"14","author":"M Elovainio","year":"2007","unstructured":"Elovainio M, Teperi J, Aalto AM (2007) Depressive symptoms as predictors of discontinuation of Levonorgestrel releasing intrauterine system. Int J Behav Med 14:70\u20135","journal-title":"Int J Behav Med"},{"key":"346_CR30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","volume":"9","author":"J Endicott","year":"2006","unstructured":"Endicott J, Nee J, Harrison W (2006) Daily record of severity of problems (DRSP): reliability and validity. Arch Womens Ment Health 9:41\u20139","journal-title":"Arch Womens Ment Health"},{"key":"346_CR31","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.59.9.851","volume":"59","author":"CN Epperson","year":"2002","unstructured":"Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman DL, Krystal JH (2002) Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psych 59:851\u20138","journal-title":"Arch Gen Psych"},{"key":"346_CR32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1176\/appi.ajp.2012.11081302","volume":"169","author":"CN Epperson","year":"2012","unstructured":"Epperson CN, Steiner M, Hartlage SA, Eriksoon E, Schmidt P, Jones I, Yonkers KA (2012) Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psych 169:465\u201375","journal-title":"Am J Psych"},{"key":"346_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0893-133X(94)00076-C","volume":"12","author":"E Eriksson","year":"1995","unstructured":"Eriksson E, Hedberg MA, Andersch B, Sundblad C (1995) The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12:167\u201376","journal-title":"Neuropsychopharmacology"},{"key":"346_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/JCP.0b013e3181678a28","volume":"28","author":"E Eriksson","year":"2008","unstructured":"Eriksson E, Ekman A, Sinclair S, S\u00f6rvik K, Ysander C, Mattson UB, Nissbrandt H (2008) Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder. J Clin Psychopharmacol 28:195\u2013202","journal-title":"J Clin Psychopharmacol"},{"key":"346_CR35","first-page":"303","volume":"33","author":"EW Freeman","year":"1997","unstructured":"Freeman EW, Sondheimer SJ, Rickels K (1997) Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 33:303\u20139","journal-title":"Psychopharmacol Bull"},{"key":"346_CR36","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.56.10.932","volume":"56","author":"EW Freeman","year":"1999","unstructured":"Freeman EW, Rickels K, Sondheimer SJ, Polansky M (1999) Differential response to antidepressants in women with premenstrual syndrome\/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry 56:932\u20139","journal-title":"Arch Gen Psychiatry"},{"key":"346_CR37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","volume":"10","author":"EW Freeman","year":"2001","unstructured":"Freeman EW, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, Zhang P, Patel H, Foegh M (2001) Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med 10:561\u20139","journal-title":"J Womens Health Gend Based Med"},{"key":"346_CR38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0020-7292(02)00033-4","volume":"77","author":"EW Freeman","year":"2002","unstructured":"Freeman EW, Stout AL, Endicott J, Spiers P (2002) Treatment of premenstrual syndrome with a carbohydrate-rich beverage. Int J Gynaecol Obstet 77:253\u201354","journal-title":"Int J Gynaecol Obstet"},{"key":"346_CR39","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/AOG.0b013e318236edf2","volume":"118","author":"EW Freeman","year":"2011","unstructured":"Freeman EW, Sammel MD, Lin H, Rickels K, Sondheimer J (2011) Clinical subtypes of premenstrual syndrome and responses to sertraline treatment. Obstet Gynecol 118:1293\u20131300","journal-title":"Obstet Gynecol"},{"key":"346_CR40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2011.09.010","volume":"85","author":"EW Freeman","year":"2012","unstructured":"Freeman EW, Halbreich U, Grubb GS, Rapkin AJ, Skouby SO, Smith L, Mirkin S, Constantine GD (2012) An overview of four studies of a continuous oral contraceptive (levonorgestrel 90\u00a0mcg\/ethinyl estradiol 20\u00a0mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception 85:437\u201345","journal-title":"Contraception"},{"key":"346_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","volume":"36","author":"CA Graham","year":"1992","unstructured":"Graham CA, Sherwin BB (1992) A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 36:257\u201366","journal-title":"J Psychosom Res"},{"key":"346_CR42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-4530(94)00053-D","volume":"20","author":"PM Hahn","year":"1995","unstructured":"Hahn PM, Van Vugt DA, Reid RL (1995) A randomized, placebo-controlled crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 20:193\u2013209","journal-title":"Psychoneuroendocrinology"},{"key":"346_CR43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0029-7844(02)02326-8","volume":"100","author":"U Halbreich","year":"2002","unstructured":"Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L (2002) Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstet Gynecol 100:1219\u20131229","journal-title":"Obstet Gynecol"},{"issue":"suppl 3","key":"346_CR44","first-page":"1","volume":"28","author":"U Halbreich","year":"2003","unstructured":"Halbreich U, Borenstein J, Pearlstein T, Kahn LS (2003) The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD). Psychoneuroendocrinology 28(suppl 3):1\u201323","journal-title":"Psychoneuroendocrinology"},{"key":"346_CR45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2011.05.008","volume":"85","author":"U Halbreich","year":"2012","unstructured":"Halbreich U, Freeman EW, Rapkin AJ, Cohen LS, Grubb GS, Bergeron R, Smith L, Mirkin S, Constantine GD (2012) Continuous oral levonorgestrel\/ethinyl estradiol for treating premenstrual dysphoric disorder. Contraception 85:19\u201327","journal-title":"Contraception"},{"key":"346_CR46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/00016348809004191","volume":"67","author":"S Hammarb\u00e4ck","year":"1988","unstructured":"Hammarb\u00e4ck S, B\u00e4ckstr\u00f6m T (1988) Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstet Gynecol Scand 67:159\u201366","journal-title":"Acta Obstet Gynecol Scand"},{"key":"346_CR47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/00016348909020997","volume":"68","author":"S Hammarb\u00e4ck","year":"1989","unstructured":"Hammarb\u00e4ck S, B\u00e4ckstr\u00f6m T (1989) A demographic study in subgroups of women seeking help for premenstrual syndrome. Acta Obstet Gynecol Scand 68:247\u201353","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"346_CR48","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archgenpsychiatry.2011.1368","volume":"69","author":"SA Hartlage","year":"2012","unstructured":"Hartlage SA, Freels A, Gotman N, Yonkers KA (2012) Criteria for premenstrual dysphoric disorder (PMDD): secondary analyses of relevant data sets. Arch Gen Psychiatry 69(3):300\u20135","journal-title":"Arch Gen Psychiatry"},{"key":"346_CR49","first-page":"15","volume":"45","author":"RH Howland","year":"2007","unstructured":"Howland RH (2007) Managing common side effects of SSRIs. Psychopharm 45:15\u201318","journal-title":"Psychopharm"},{"key":"346_CR50","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0022-3999(02)00338-0","volume":"53","author":"MS Hunter","year":"2002","unstructured":"Hunter MS, Ussher JM, Cariss M, Browne S, Jelley R, Katz M (2002) Medical (fluoxetine) and psychological (cognitive-behavioural therapy) treatment for premenstrual dysphoric disorder: a study of treatment processes. J Psychosom Res 53:811\u20137","journal-title":"J Psychosom Res"},{"key":"346_CR51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/09513599209081007","volume":"6","author":"SY Hussain","year":"1992","unstructured":"Hussain SY, Massil JH, Matta WH, Shaw RW, O'Brien PM (1992) Buserelin in premenstrual syndrome. Gynecol Endocrinol 6:57\u201364","journal-title":"Gynecol Endocrinol"},{"key":"346_CR52","first-page":"340","volume":"33","author":"SR Johnson","year":"1988","unstructured":"Johnson SR, McChesney C, Bean JA (1988) Epidemiology of premenstrual symptoms in a nonclinical sample\u2014I: prevalence, natural history and help-seeking behavior. J Repro Med 33:340\u201346","journal-title":"J Repro Med"},{"key":"346_CR53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijgo.2009.01.016","volume":"105","author":"M Khajehei","year":"2009","unstructured":"Khajehei M, Abdali K, Parsanezhad ME, Tabatabaee HR (2009) Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome. Int J Gynaecol Obstet 105:158\u201361","journal-title":"Int J Gynaecol Obstet"},{"key":"346_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00737-005-0102-z","volume":"9","author":"N Kurshan","year":"2006","unstructured":"Kurshan N, Epperson CN (2006) Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model. Arch Women Ment Health 9:1\u201314","journal-title":"Arch Women Ment Health"},{"key":"346_CR55","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.npp.1301216","volume":"32","author":"M L\u00e4nden","year":"2007","unstructured":"L\u00e4nden M, Nissbrandt H, Allgulander C, Sorvik K, Ysander C, Eriksson E (2007) Placebo controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder. Neuropsychopharmacology 32:153\u201361","journal-title":"Neuropsychopharmacology"},{"key":"346_CR56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/09513599909167531","volume":"13","author":"AT Leather","year":"1999","unstructured":"Leather AT, Studd JWW, Watson NR, Holland EFN (1999) The treatment of severe premenstrual syndrome with goserelin with and without \u2018add-back\u2019 estrogen therapy: a placebo controlled study. Gynecol Endocrinol 13:48\u201355","journal-title":"Gynecol Endocrinol"},{"key":"346_CR57","doi-asserted-by":"crossref","unstructured":"Lopez LM, Kaptein AA, Helmerhorst FM (2009) Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. (2):CD006586","DOI":"10.1002\/14651858.CD006586.pub3"},{"key":"346_CR58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00737-009-0052-y","volume":"12","author":"MK Lustyk","year":"2009","unstructured":"Lustyk MK, Gerrish WG, Shaver S, Keys SL (2009) Cognitive\u2013behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Women Ment Health 12:85\u201396","journal-title":"Arch Women Ment Health"},{"key":"346_CR59","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/bmj.292.6536.1629","volume":"292","author":"AL Magos","year":"1986","unstructured":"Magos AL, Brincat M, Studd JWW (1986) Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral noresthisterone: placebo controlled study. BMJ 292:1629\u201333","journal-title":"BMJ"},{"key":"346_CR60","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","volume":"232","author":"MD Majewska","year":"1986","unstructured":"Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004\u20131007","journal-title":"Science"},{"key":"346_CR61","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jc.78.5.1003","volume":"78","author":"SH Mellon","year":"1994","unstructured":"Mellon SH (1994) Neurosteroids: biochemistry, modes of action, and clinical relevance. J Clin Endocrinol Metab 78:1003\u20138","journal-title":"J Clin Endocrinol Metab"},{"key":"346_CR62","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(16)57053-8","volume":"62","author":"G Mezrow","year":"1994","unstructured":"Mezrow G, Shoupe D, Spicer D, Lobo R, Leung B, Pike M (1994) Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Fertil Steril 62:932\u20137","journal-title":"Fertil Steril"},{"key":"346_CR63","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-2918(02)85043-3","volume":"24","author":"C Miner","year":"2002","unstructured":"Miner C, Brown E, McCray S, Gonzales J, Wohlreich M (2002) Weekly luteal-phase dosing with enteric-coated fluoxetine 90\u00a0mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial. Clin Ther 24:417\u2013433","journal-title":"Clin Ther"},{"key":"346_CR64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00042192-200207000-00004","volume":"9","author":"MF Mitwally","year":"2002","unstructured":"Mitwally MF, Gotlieb L, Casper RF (2002) Prevention of bone loss and hypestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. Menopause 9:236\u201341","journal-title":"Menopause"},{"key":"346_CR65","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881108093582","volume":"23","author":"C Moret","year":"2009","unstructured":"Moret C, Isaac M, Briley M (2009) Problems associated with long-term treatment with selective serotonin reuptake inhibitors. J Psychopharm 23:967\u2013974","journal-title":"J Psychopharm"},{"key":"346_CR66","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM198411223112104","volume":"311","author":"KN Muse","year":"1984","unstructured":"Muse KN, Cetel NS, Futterman LA, Yen SC (1984) The premenstrual syndrome. Effects of \"medical ovariectomy\". N Engl J Med 311:1345\u20139","journal-title":"N Engl J Med"},{"key":"346_CR67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1358\/dot.2008.44.2.1191059","volume":"44","author":"HG Nurnberg","year":"2008","unstructured":"Nurnberg HG (2008) An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction. Drugs Today 44:147\u201368","journal-title":"Drugs Today"},{"key":"346_CR68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9378(99)70142-0","volume":"180","author":"PMS O\u2019Brien","year":"1999","unstructured":"O\u2019Brien PMS, Abukhalil IEH (1999) Randomised controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase only danazol. Am J Obstet Gynecol 180:18\u201323","journal-title":"Am J Obstet Gynecol"},{"key":"346_CR69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00737-010-0201-3","volume":"14","author":"PMS O\u2019Brien","year":"2011","unstructured":"O\u2019Brien PMS, B\u00e4ckstr\u00f6m T, Brown C, Dennerstein L, Endicott J, Neill et al (2011) Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD consensus. Arch Women Ment Health 14:13\u201321","journal-title":"Arch Women Ment Health"},{"key":"346_CR70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-0327(01)00356-1","volume":"70","author":"KA Oinonen","year":"2002","unstructured":"Oinonen KA, Mazmanian D (2002) To what extent do oral contraceptives influence mood and affect? J Affect Disord 70:229\u201340","journal-title":"J Affect Disord"},{"key":"346_CR71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","volume":"56","author":"RW Olsen","year":"2009","unstructured":"Olsen RW, Sieghart W (2009) GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56:141\u20138","journal-title":"Neuropharmacology"},{"key":"346_CR72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.psychres.2007.11.017","volume":"30","author":"BL Parry","year":"2008","unstructured":"Parry BL, Meliska CJ, Mart\u00ednez LF, L\u00f3pez AM, Sorenson DL, Hauger RL, Elliott JA (2008) Later, but not early, wake therapy reduces morning plasma melatonin: relationship to mood in premenstrual dysphoric disorder. Psychiatry Res 30:76\u201386","journal-title":"Psychiatry Res"},{"key":"346_CR73","doi-asserted-by":"crossref","unstructured":"Pearlstein TB, Stone AB, Lund SA, Scheft H, Zlotnick C, Brown WA (1997) Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 17:261\u20136","DOI":"10.1097\/00004714-199708000-00004"},{"key":"346_CR74","doi-asserted-by":"crossref","unstructured":"Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA (2005) Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 72:414\u201321","DOI":"10.1016\/j.contraception.2005.08.021"},{"key":"346_CR75","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jpsychires.2010.07.006","volume":"45","author":"SM Pincus","year":"2011","unstructured":"Pincus SM, Alam S, Rubinow DR, Bhuvaneswar CG, Schmidt PJ (2011) Predicting response to leuprolide of women with premenstrual dysphoric disorder by daily mood rating dynamics. J Psychiatr Res 45:386\u201394","journal-title":"J Psychiatr Res"},{"key":"346_CR76","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0895-4356(92)90039-P","volume":"45","author":"S Ramacharan","year":"1992","unstructured":"Ramacharan S, Love EJ, Fick GH, Goldfien A (1992) The epidemiology of premenstrual symptoms in a population based sample of 2650 urban women. J Clin Epidemiol 45:377\u201381","journal-title":"J Clin Epidemiol"},{"key":"346_CR77","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1176\/ajp.147.12.1634","volume":"147","author":"AD Rivera-Tovar","year":"1990","unstructured":"Rivera-Tovar AD, Frank E (1990) Late luteal phase dysphoric disorder in young women. Am J Psychiatry 147:1634\u201336","journal-title":"Am J Psychiatry"},{"key":"346_CR78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-4755-8-2","volume":"8","author":"EA Rocha Filho","year":"2011","unstructured":"Rocha Filho EA, Lima JC, Pinho Neto JS, Montarroyos U (2011) Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study. Reprod Health 8:2","journal-title":"Reprod Health"},{"key":"346_CR79","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG) (2007) Management of Premenstrual Syndrome (Green-top Guideline No. 48). http:\/\/www.rcog.org.uk\/files\/rcog-corp\/uploaded-files\/GT48ManagementPremensturalSyndrome.pdf . Accessed 10 May 2009"},{"key":"346_CR80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0029-7844(95)00246-N","volume":"64","author":"SA Sanders","year":"2001","unstructured":"Sanders SA, Graham CA, Bass JL, Bancroft J (2001) A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 64:51\u20138","journal-title":"Contraception"},{"key":"346_CR81","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0029-7844(95)00246-N","volume":"86","author":"R Sayegh","year":"1995","unstructured":"Sayegh R, Schiff I, Wurtman J, Spiers P, McDermott J, Wurtman R (1995) The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 86:520\u20138","journal-title":"Obstet Gynecol"},{"key":"346_CR82","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199104253241705","volume":"324","author":"PJ Schmidt","year":"1991","unstructured":"Schmidt PJ, Nieman LK, Grover GN, Muller KL, Merriam GR, Rubinow DR (1991) Lack on effect of induced menses of symptoms on women with premenstrual syndrome. N Engl J Med 324:1174\u20131179","journal-title":"N Engl J Med"},{"key":"346_CR83","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archpsyc.1993.01820180069007","volume":"50","author":"PJ Schmidt","year":"1993","unstructured":"Schmidt PJ, Grover GN, Rubinow DR (1993) Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial. Arch Gen Psychiatry 50:467\u201373","journal-title":"Arch Gen Psychiatry"},{"key":"346_CR84","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","volume":"338","author":"PJ Schmidt","year":"1998","unstructured":"Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338:209\u201316","journal-title":"N Engl J Med"},{"key":"346_CR85","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajog.2009.03.016","volume":"201","author":"B Segebladh","year":"2009","unstructured":"Segebladh B, Borgstr\u00f6m A, Nyberg S, Bixo M, Sundstr\u00f6m-Poromaa I (2009) Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Am J Obstet Gynecol 201:139, e1-8","journal-title":"Am J Obstet Gynecol"},{"key":"346_CR86","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/AOG.0b013e31816fd73b","volume":"111","author":"NR Shah","year":"2008","unstructured":"Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borensstein J (2008) Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 111:1175\u20131182","journal-title":"Obstet Gynecol"},{"key":"346_CR87","doi-asserted-by":"crossref","first-page":"259345","DOI":"10.1155\/2010\/259345","volume":"2010","author":"A Shechter","year":"2010","unstructured":"Shechter A, Boivin DB (2010) Sleep, hormones, and circadian rhythms throughout the menstrual cycle in healthy women and women with premenstrual dysphoric disorder. Int J Endocrinol 2010:259345","journal-title":"Int J Endocrinol"},{"key":"346_CR88","first-page":"6475","volume":"102","author":"RNH Smith","year":"1995","unstructured":"Smith RNH, Studd JWW, Zamblera D, Holland EFN (1995) A randomised comparison over 8\u00a0months of 100\u00a0mcgs and 200\u00a0mcg twice weekly doses in the treatment of severe premenstrual syndrome. Br J Obstet Gynaecol 102:6475\u201384","journal-title":"Br J Obstet Gynaecol"},{"key":"346_CR89","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1089\/152460901753285778","volume":"10","author":"C Soares","year":"2001","unstructured":"Soares C, Cohen L, Otto M, Harlow B (2001) Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard study of moods and cycles. J Women\u2019s Health Gend Based Med 10:873\u201378","journal-title":"J Women\u2019s Health Gend Based Med"},{"issue":"Suppl 12","key":"346_CR90","first-page":"17","volume":"61","author":"M Steiner","year":"2000","unstructured":"Steiner M, Pearlstein T (2000) Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. J Clin Psychiatry 61(Suppl 12):17\u201321","journal-title":"J Clin Psychiatry"},{"key":"346_CR91","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00737-003-0018-4","volume":"6","author":"M Steiner","year":"2003","unstructured":"Steiner M, Macdougall M, Brown E (2003) The premenstrual symptoms screening tool (PSST) for clinicians. Arch Women Ment Health 6:203\u2013209","journal-title":"Arch Women Ment Health"},{"key":"346_CR92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00737-010-0202-2","volume":"14","author":"M Steiner","year":"2011","unstructured":"Steiner M, Peer M, Palova E, Freeman EW, Macdougall M, Soares CN (2011) The premenstrual symptoms screening tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents. Arch Women Ment Health 14:77\u201381","journal-title":"Arch Women Ment Health"},{"key":"346_CR93","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/13697137.2011.609285","volume":"14","author":"J Studd","year":"2011","unstructured":"Studd J (2011) A guide to the treatment of depression women by hormones. Climacteric 14:637\u201342","journal-title":"Climacteric"},{"key":"346_CR94","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1993.52","volume":"9","author":"C Sundblad","year":"1993","unstructured":"Sundblad C, Hedberg MA, Eriksson E (1993) Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology 9:133\u2013145","journal-title":"Neuropsychopharmacology"},{"key":"346_CR95","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/j.1600-0412.1999.781011.x","volume":"78","author":"I Sundstrom","year":"1999","unstructured":"Sundstrom I, Nyberg S, Bixo M, Hammarb\u00e4ck S, B\u00e4ckstr\u00f6m T (1999) Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 78:891\u20139","journal-title":"Acta Obstet Gynecol Scand"},{"key":"346_CR96","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/j.1600-0412.2000.079005405.x","volume":"79","author":"H Sveind\u00f3ttir","year":"2000","unstructured":"Sveind\u00f3ttir H, B\u00e4ckstr\u00f6m T (2000) Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 79:405\u201313","journal-title":"Acta Obstet Gynecol Scand"},{"key":"346_CR97","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","volume":"179","author":"S Thys-Jacobs","year":"1998","unstructured":"Thys-Jacobs S, Starkey P, Bernstein D, Tian J (1998) Calcium carbonate and the premenstrual syndrome: effects of premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group Am J Obstet Gynecol 179:444\u201352","journal-title":"Premenstrual Syndrome Study Group Am J Obstet Gynecol"},{"key":"346_CR98","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(89)90784-8","volume":"ii","author":"NR Watson","year":"1989","unstructured":"Watson NR, Studd JWW, Savvas M, Garnett T, Baber RJ (1989) Treatment of severe pre-menstrual syndrome with estradiol patched and cyclical oral noresthisterone. Lancet ii:730\u2013734","journal-title":"Lancet"},{"key":"346_CR99","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/oxfordjournals.humrep.a138633","volume":"9","author":"CP West","year":"1994","unstructured":"West CP, Hillier H (1994) Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome. Hum Reprod 9:1058\u201363","journal-title":"Hum Reprod"},{"key":"346_CR100","first-page":"407","volume":"16","author":"AM Whelan","year":"2009","unstructured":"Whelan AM, Jurgens TM, Naylor H (2009) Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol 16:407\u201329","journal-title":"Can J Clin Pharmacol"},{"key":"346_CR101","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0033291701004925","volume":"32","author":"HU Wittchen","year":"2002","unstructured":"Wittchen HU, Becker E, Lieb R, Krause P (2002) Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32:119\u2013132","journal-title":"Psychol Med"},{"key":"346_CR102","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2105\/AJPH.72.11.1257","volume":"72","author":"NF Woods","year":"1982","unstructured":"Woods NF, Most A, Dery GK (1982) Prevalence of perimenstrual symptoms. Am J Public Health 72:1257\u201364","journal-title":"Am J Public Health"},{"key":"346_CR103","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.318.7195.1375","volume":"318","author":"KM Wyatt","year":"1999","unstructured":"Wyatt KM, Dimmock PW, Jones PW, O\u2019Brien PMS (1999) Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 318:1375\u201381","journal-title":"BMJ"},{"key":"346_CR104","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","volume":"111","author":"KM Wyatt","year":"2004","unstructured":"Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O'Brien PM (2004) The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta-analysis. BJOG 111:585\u201393","journal-title":"BJOG"},{"key":"346_CR105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","volume":"106","author":"KA Yonkers","year":"2005","unstructured":"Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A (2005) Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 106:492\u2013501","journal-title":"Obstet Gynecol"},{"key":"346_CR106","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","volume":"371","author":"KA Yonkers","year":"2008","unstructured":"Yonkers KA, O\u2019Brien PMS, Eriksson E (2008) Premenstrual syndrome. Lancet 371:1200\u201310","journal-title":"Lancet"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-013-0346-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00737-013-0346-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-013-0346-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T02:38:08Z","timestamp":1562985488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00737-013-0346-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,27]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1007\/s00737-013-0346-y","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,27]]}}}